News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
858,496 Results
Type
Article (87274)
Company Profile (738)
Press Release (770456)
Multimedia
Podcasts (165)
Webinars (26)
Section
Business (232993)
Career Advice (4137)
Deals (39782)
Drug Delivery (133)
Drug Development (91214)
Employer Resources (201)
FDA (18251)
Job Trends (17389)
News (397237)
Policy (39906)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (121)
Alliances (56979)
ALS (137)
Alzheimer's disease (1650)
Antibody-drug conjugate (ADC) (206)
Approvals (18255)
Artificial intelligence (460)
Autoimmune disease (49)
Automation (23)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (152)
Biotechnology (483)
Bladder cancer (118)
Brain cancer (47)
Breast cancer (441)
Cancer (3570)
Cardiovascular disease (313)
Career advice (3551)
Career pathing (36)
CAR-T (232)
CDC (51)
Cell therapy (633)
Cervical cancer (29)
Clinical research (74989)
Collaboration (1295)
Company closure (4)
Compensation (870)
Complete response letters (51)
COVID-19 (2942)
CRISPR (78)
C-suite (516)
Cystic fibrosis (130)
Data (3859)
Decentralized trials (2)
Denatured (59)
Depression (102)
Diabetes (431)
Diagnostics (7053)
Digital health (30)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (219)
Drug pricing (170)
Drug shortages (36)
Duchenne muscular dystrophy (184)
Earnings (98645)
Editorial (53)
Employer branding (25)
Employer resources (170)
Events (132468)
Executive appointments (960)
FDA (20521)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (11)
Funding (1146)
Gene editing (165)
Generative AI (45)
Gene therapy (501)
GLP-1 (1002)
Government (5354)
Grass and pollen (7)
Guidances (334)
Healthcare (20934)
HIV (48)
Huntington's disease (34)
IgA nephropathy (52)
Immunology and inflammation (227)
Immuno-oncology (19)
Indications (49)
Infectious disease (3163)
Inflammatory bowel disease (180)
Inflation Reduction Act (13)
Influenza (87)
Intellectual property (168)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2863)
Kidney cancer (15)
Labor market (71)
Layoffs (628)
Leadership (31)
Legal (10144)
Liver cancer (90)
Longevity (12)
Lung cancer (514)
Lymphoma (252)
Machine learning (23)
Management (65)
Manufacturing (580)
MASH (121)
Medical device (14834)
Medtech (14852)
Mergers & acquisitions (22680)
Metabolic disorders (1093)
Multiple sclerosis (123)
NASH (23)
Neurodegenerative disease (188)
Neuropsychiatric disorders (52)
Neuroscience (2569)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (54)
Obesity (544)
Opinion (304)
Ovarian cancer (115)
Pain (156)
Pancreatic cancer (149)
Parkinson's disease (216)
Partnered (28)
Patents (388)
Patient recruitment (272)
Peanut (57)
People (66085)
Pharmaceutical (143)
Pharmacy benefit managers (25)
Phase I (23116)
Phase II (32567)
Phase III (24507)
Pipeline (2502)
Policy (282)
Postmarket research (3554)
Preclinical (10442)
Press Release (72)
Prostate cancer (176)
Psychedelics (50)
Radiopharmaceuticals (281)
Rare diseases (611)
Real estate (7412)
Recruiting (77)
Regulatory (27748)
Reports (64)
Research institute (2677)
Resumes & cover letters (650)
Rett syndrome (12)
RNA editing (15)
RSV (65)
Schizophrenia (123)
Series A (190)
Series B (143)
Service/supplier (30)
Sickle cell disease (77)
Special edition (25)
Spinal muscular atrophy (168)
Sponsored (40)
Startups (4315)
State (2)
Stomach cancer (17)
Supply chain (95)
Tariffs (84)
The Weekly (104)
Vaccines (1014)
Venture capital (63)
Weight loss (379)
Women's health (56)
Worklife (21)
Date
Today (86)
Last 7 days (560)
Last 30 days (2393)
Last 365 days (33847)
2025 (24035)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (78)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50831)
Australia (8925)
California (8971)
Canada (2726)
China (853)
Colorado (379)
Connecticut (401)
Delaware (243)
Europe (116728)
Florida (1319)
Georgia (305)
Hawaii (3)
Idaho (67)
Illinois (788)
India (47)
Indiana (435)
Iowa (19)
Japan (276)
Kansas (123)
Kentucky (35)
Louisiana (20)
Maine (75)
Maryland (1224)
Massachusetts (6752)
Michigan (298)
Minnesota (545)
Mississippi (4)
Missouri (113)
Montana (32)
Nebraska (26)
Nevada (102)
New Hampshire (76)
New Jersey (2477)
New Mexico (32)
New York (2446)
North Carolina (1368)
North Dakota (10)
Northern California (3995)
Ohio (281)
Oklahoma (19)
Oregon (49)
Pennsylvania (1868)
Puerto Rico (18)
Rhode Island (44)
South America (1655)
South Carolina (45)
South Dakota (1)
Southern California (3415)
Tennessee (142)
Texas (1403)
United States (33270)
Utah (268)
Virginia (239)
Washington D.C. (82)
Washington State (772)
West Virginia (4)
Wisconsin (92)
There are 858,496 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Multiple sclerosis
FDA Action Date for Sanofi’s Oral Multiple Sclerosis Drug Bumped to December
The company was expecting a decision from the FDA by Sept. 28 for its oral drug tolebrutinib, but an update to the drug’s application package convinced the agency to take more time to review.
September 22, 2025
·
1 min read
·
Dan Samorodnitsky
Mergers & acquisitions
Pfizer Stages Obesity Comeback With $4.9B Metsera Acquisition
The acquisition of breakout obesity star Metsera should pump new life into Pfizer’s portfolio, which over the last two years has suffered from three discontinued assets.
September 22, 2025
·
2 min read
·
Tristan Manalac
Press Releases
BioHarvest Sciences Strengthens Balance Sheet by $14.7 Million with Injection of $10.9 Million Gross Proceeds and Additional $3.8 Million in Debt Reduction
September 22, 2025
·
3 min read
Press Releases
Envoy Medical Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
September 22, 2025
·
5 min read
Press Releases
Pharmaceutical Market Poised for Growth, Expected to Hit USD 3.12 Tillion by 2032 | Coherent Market Insights
September 22, 2025
·
1 min read
Press Releases
Tuberculosis Therapeutics Market to Hit USD 2.11 Billion in 2025 on Rising Disease Burden
September 22, 2025
·
1 min read
Press Releases
Clinical Nutrition Market Poised for Growth, Expected to Hit USD 19.77 Billion by 2032 -Coherent Market Insights
September 22, 2025
·
1 min read
Press Releases
DNA Sequencing Market to Reach USD 18,412.4 Million in 2032, Driven by Expanding Medical Applications
September 22, 2025
·
1 min read
Press Releases
Viral Vector and Plasmid DNA Manufacturing Market Size to Surpass USD 40.71 Billion by 2034
September 22, 2025
·
1 min read
Press Releases
Oncology Market Poised to Reach USD 600.97 Billion by 2034, Growing at 11.54% CAGR
September 22, 2025
·
1 min read
1 of 85,850
Next
